{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:56:30Z","timestamp":1791982590624,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["JP26460190"],"award-info":[{"award-number":["JP26460190"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.04.050","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T00:46:38Z","timestamp":1493513198000},"page":"2509-2514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes"],"prefix":"10.1016","volume":"106","author":[{"given":"Eiichiro","family":"Ogimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Tokizono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.050_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In\u00a0vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.050_bib3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.tiv.2011.11.002","article-title":"BSEP inhibition: in\u00a0vitro screens to assess cholestatic potential of drugs","volume":"26","author":"Kis","year":"2012","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.050_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A\u00a0gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.050_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfv231","article-title":"Inhibition of human hepatic bile acid transporters by tolvaptan and metabolites: contributing factors to drug-induced liver injury?","volume":"149","author":"Slizgi","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.xphs.2017.04.050_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfw193","article-title":"Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors","volume":"155","author":"Woodhead","year":"2017","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.050_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2125.2011.04114.x","article-title":"Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects","volume":"73","author":"Shoaf","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.050_bib9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s12272-014-0352-2","article-title":"Liquid chromatography-tandem mass spectrometry method for determining tolvaptan and its nine metabolites in rat serum: application to a pharmacokinetic study","volume":"37","author":"Furukawa","year":"2014","journal-title":"Arch Pharm Res"},{"issue":"3-4","key":"10.1016\/j.xphs.2017.04.050_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2011.11.032","article-title":"Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes","volume":"416","author":"Ogimura","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.050_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.xphs.2016.01.013","article-title":"Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells","volume":"105","author":"Susukida","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.109.028407","article-title":"An in\u00a0vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes","volume":"38","author":"Ansede","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.050_bib13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1124\/dmd.115.065425","article-title":"Prediction of the clinical risk of drug-induced cholestatic liver injury using an in\u00a0vitro sandwich cultured hepatocyte assay","volume":"43","author":"Susukida","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.050_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in\u00a0vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.050_bib15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.tiv.2015.06.004","article-title":"Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes","volume":"29","author":"Susukida","year":"2015","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"30","key":"10.1016\/j.xphs.2017.04.050_bib16","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.050_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A\u00a0pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J\u00a0Pharmacobiodyn"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.050_bib18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garc\u00eda-Ca\u00f1averas","year":"2012","journal-title":"J\u00a0Lipid Res"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.050_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.050_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/dmd.115.067074","article-title":"Analysis of the metabolic pathway of bosentan and of the cytotoxicity of bosentan metabolites based on a quantitative modeling of metabolism and transport in sandwich-cultured human hepatocytes","volume":"44","author":"Matsunaga","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.050_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4062\/biomolther.2016.153","article-title":"Bosentan and rifampin interactions modulate\u00a0influx transporter and cytochrome P450 expression and activities\u00a0in primary human hepatocytes","volume":"25","author":"Han","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/dmd.111.039297","article-title":"Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes","volume":"40","author":"Kimoto","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1248\/bpb.b14-00767","article-title":"Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs","volume":"38","author":"Maeda","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.050_bib24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jps.24564","article-title":"Clearance prediction of HIV protease inhibitors in man: role of hepatic uptake","volume":"105","author":"De Bruyn","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.050_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1139\/Y10-060","article-title":"Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes","volume":"88","author":"Hartman","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.050_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.toxlet.2009.03.022","article-title":"Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture","volume":"188","author":"Langsch","year":"2009","journal-title":"Toxicol Lett"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.050_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0006-2952(97)00204-9","article-title":"Drug metabolism in hepatocyte sandwich cultures of rats and humans","volume":"54","author":"Kern","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.050_bib28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1208\/s12248-016-9962-6","article-title":"Challenges and opportunities with non-CYP enzymes aldehyde oxidase, carboxylesterase, and UDP-glucuronosyltransferase: focus on reaction phenotyping and prediction of human clearance","volume":"18","author":"Argikar","year":"2016","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.050_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/mol.59.3.627","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in\u00a0vivo and in\u00a0vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.050_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"Funk","year":"2001","journal-title":"Toxicology"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T06:51:03Z","timestamp":1535871063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917303192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917303192"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.050","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}